QXO Inc
QXO
11.31
-0.80
-6.61%
QXO Inc
US · QXO
#1316 by market cap
Listed 1970
11.31
-0.80
-6.61%
Live - 5344 symbols - heartbeat 136s ago
· 2026-10-08 06:42
Pre-market
11.05
-2.30%
After-hours
11.28
-0.27%
Overnight
11.21
-0.88%
- Market cap
- 11.73B
- P/E (TTM)i
- -12.29
- P/Bi
- 1.26
- EPSi
- -0.63
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on QXO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.79, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11,924.96% YoY
Margins
- Gross margin
- 22.99%
- Operating margin
- -3.58%
- Net margin
- -5.68%
Key ratios & quality
- Enterprise valuei
- 12.59B
- Altman Z-Scorei
- 1.79
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 36.10M | 38.50M | 41.22M | 41.70M | 44.99M | 54.52M | 56.90M | 6.84B |
| Gross profit | 13.85M | 14.68M | 16.58M | 17.21M | 17.96M | 21.61M | 23.10M | 1.57B |
| Selling & admin expenses | 14.37M | 15.63M | 15.65M | 16.56M | 17.40M | 22.10M | 93.00M | 1.39B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -1.16M | -1.67M | 223.39K | -230.99K | -385.38K | -1.31M | -71.00M | -245.20M |
| Pretax profit | -1.20M | -1.92M | 223.04K | 43.57K | -474.40K | -1.37M | 50.80M | -337.10M |
| Tax | -281.21K | -455.01K | 47.39K | 178.01K | -192.18K | -297.00K | 22.80M | -57.70M |
| Net profit | 262.43K | 6.79M | 175.65K | -134.43K | -282.22K | -1.07M | 28.00M | -279.40M |
| Basic EPS | 0 | 12 | 0 | 0 | 0 | -2 | 0 | -1 |
| Diluted EPS | 0.48 | 12.08 | 0.32 | -0.24 | -0.40 | -1.63 | -0.11 | -0.63 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 13.50M | 1.91B | 2.73B | 2.19B | 1.73B | 3.25B |
| Gross profit | 5.40M | 401.00M | 635.80M | 529.90M | 409.30M | 803.00M |
| Selling & admin expenses | 44.40M | 457.00M | 452.50M | 441.10M | 497.00M | 649.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -39.30M | -163.00M | 25.80M | -69.50M | -251.90M | -42.00M |
| Pretax profit | 17.30M | -237.00M | -10.50M | -107.50M | -280.30M | -77.00M |
| Tax | 8.50M | -178.00M | 128.90M | -17.30M | -53.20M | -22.00M |
| Net profit | 8.80M | -59.00M | -139.40M | -90.20M | -227.10M | -55.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.03 | -0.15 | -0.24 | -0.17 | -0.35 | -0.14 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.89M | 12.98M | 8.63M | 10.71M | 13.70M | 11.80M | 5.09B | 5.55B |
| Cash & ST investments | 1.90M | 8.66M | 6.60M | 6.81M | 8.01M | 6.14M | 5.07B | 2.36B |
| Inventory | -- | -- | -- | -- | -- | -- | 0 | 1.50B |
| Total assets | 11.74M | 18.95M | 15.90M | 18.00M | 21.44M | 20.50M | 5.10B | 15.89B |
| Total current liabilities | 6.23M | 8.66M | 6.73M | 7.39M | 10.75M | 11.52M | 45.10M | 1.55B |
| Short-term debt | 513.71K | 833.55K | 1.14M | 1.03M | 1.27M | 1.12M | 300.00K | 156.70M |
| Long-term debt | 1.07M | 781.55K | 937.34K | 566.94K | 671.01K | 994.00K | -- | 3.06B |
| Total liabilities | 7,410,225.00 | 10,058,612.00 | 8,621,416.00 | 8,641,939.00 | 11,885,603.00 | 13,024,000.00 | 45,400,000.00 | 6,180,500,000.00 |
| Total equity | 4.33M | 8.89M | 7.28M | 9.36M | 9.55M | 7.47M | 5.05B | 9.71B |
| Retained earnings | -7.43M | -635.58K | -459.94K | -594.37K | -876.59K | -1.95M | -6.20M | -394.50M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 5.10B | 6.49B | 6.22B | 5.55B | 6.46B | 10.35B |
| Cash & ST investments | 5.08B | 2.28B | 2.31B | 2.36B | 3.05B | 2.77B |
| Inventory | -- | 1.85B | 1.66B | 1.50B | 1.67B | 2.07B |
| Total assets | 5.11B | 17.11B | 16.64B | 15.89B | 16.66B | 22.67B |
| Total current liabilities | 53.60M | 2.17B | 2.03B | 1.55B | 1.94B | 2.52B |
| Short-term debt | 313.00K | 152.80M | 155.30M | 156.70M | 159.90M | 189.00M |
| Long-term debt | -- | 3.25B | 3.10B | 3.06B | 3.06B | 6.04B |
| Total liabilities | 53,782,000.00 | 7,198,900,000.00 | 6,821,000,000.00 | 6,180,500,000.00 | 6,495,300,000.00 | 12,287,000,000.00 |
| Total equity | 5.06B | 9.92B | 9.82B | 9.71B | 10.16B | 10.38B |
| Retained earnings | -19.97M | -104.10M | -273.90M | -394.50M | -652.00M | -761.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.29M | -397.40K | 1.73M | 226.03K | 2.04M | 584.00K | 84.80M | 261.40M |
| Depreciation & amortization | 648.41K | 932.20K | 1.12M | 1.39M | 1.76M | 1.00M | 1.10M | 423.10M |
| Free cash flow | 896.74K | -549.80K | 1.60M | 111.27K | 2.00M | 463.00K | 84.70M | 183.20M |
| Dividends paid | 0 | -225.04K | -4.05M | -3.08M | 0 | -1.05M | -32.30M | -104.80M |
| Stock buybacks / issuance | -3.66K | 0 | 0 | 4.18M | -- | 0 | 4.03B | 4.26B |
| Ending cash balance | 1.90M | 8.66M | 6.60M | 6.81M | 8.01M | 6.14M | 5.07B | 2.37B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 36.50M | -174.50M | 212.80M | 186.60M | 70.60M | -216.60M |
| Depreciation & amortization | 300.00K | 106.70M | 157.80M | 158.30M | 164.20M | 197.80M |
| Free cash flow | 36.40M | -194.40M | 183.00M | 158.20M | 48.10M | -248.10M |
| Dividends paid | -22.50M | -22.50M | -29.40M | -30.40M | -30.40M | -30.60M |
| Stock buybacks / issuance | 0 | 4.22B | 38.50M | -500.00K | 749.50M | 1.97B |
| Ending cash balance | 5.09B | 2.28B | 2.31B | 2.37B | 3.05B | 5.77B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.13 | 102.72 | 2.17 | -1.62 | -2.99 | -12.57 | -1.01 | -5.88 |
| ROA %i | 2.37 | 44.27 | 1.01 | -0.79 | -1.43 | -5.10 | -0.90 | -3.70 |
| ROIC %i | 5.36 | 79.22 | 1.74 | -0.91 | -1.80 | -9.31 | -5.23 | -4.07 |
| 5-year avg ROE %i | -- | 50.25 | 41.15 | 19.77 | 21.28 | 17.54 | -3.20 | -4.81 |
| EBIT margin %i | 1.01 | -4.34 | 0.57 | 0.22 | -0.86 | -2.41 | 89.45 | -2.39 |
| FCF / sales %i | 1.30 | -- | 3.89 | 0.27 | 4.45 | 0.85 | 149.07 | 2.68 |
| Current ratioi | 0.78 | 1.50 | 1.28 | 1.45 | 1.27 | 1.02 | 112.85 | 3.58 |
| Quick ratioi | 0.64 | 1.45 | 1.22 | 1.22 | 0.99 | 0.79 | 112.44 | 2.56 |
| Debt / assetsi | 14.40 | 11.78 | 19.10 | 12.71 | 11.19 | 12.78 | 0.01 | 24.64 |
| LT debt / equityi | 27.16 | 15.73 | 25.99 | 13.38 | 11.86 | 20.08 | 0.01 | 43.44 |
| Interest coveragei | 9.90 | -- | 17.38 | 1.93 | -4.33 | -23.57 | 847.87 | -0.94 |
| Revenue CAGR (3Y) %i | 9.31 | 4.11 | 5.75 | 4.92 | 5.32 | 9.77 | 10.91 | 433.80 |
| Net income CAGR (3Y) %i | -11.16 | 25.51 | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 147.46 | -- | 2.42 | -50.12 | -- | -33.92 | 813.06 | 350.81 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -1.62 | -2.45 | -4.19 | -5.88 | -9.25 | -6.82 |
| ROA %i | -1.44 | -1.26 | -2.57 | -3.70 | -5.81 | -3.12 |
| ROIC %i | -7.78 | -1.70 | -3.23 | -4.07 | -5.94 | -3.65 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 121.40 | -7.52 | -1.87 | -2.39 | -4.73 | -2.36 |
| FCF / sales %i | 214.81 | -- | 1.69 | 2.68 | 2.28 | 1.43 |
| Current ratioi | 95.23 | 3.00 | 3.06 | 3.58 | 3.33 | 4.11 |
| Quick ratioi | 95.09 | 2.10 | 2.19 | 2.56 | 2.42 | 2.04 |
| Debt / assetsi | 0.01 | 24.05 | 23.76 | 24.64 | 23.42 | 31.05 |
| LT debt / equityi | 0.00 | 44.73 | 43.34 | 43.44 | 41.09 | 73.47 |
| Interest coveragei | 1,543.52 | -- | -- | -0.94 | -1.76 | -0.97 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Residential roofing products is the largest reported line at 39.00% of revenue, across 4 reported segments.
- No single line clears half of revenue; Complementary building products is next at 37.86%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Residential roofing products39.00%
Complementary building products37.86%
Non-residential roofing products22.67%
Software products and services0.46%
Quote time 2026-10-08 06:42:36 · For reference only, not investment advice and not tailored to your situation.